| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.883 | 0.004 | 0.883 | Aldehyde oxidase inhibitor | 0.745 0.005 DBMET02972 0.683 0.01 DBMET02973 0.598 0.019 DBMET02974 | ||
| 0.763 | 0.005 | 0.763 | Spasmolytic | 0.609 0.012 DBMET02972 0.614 0.012 DBMET02973 0.46 0.029 DBMET02974 | ||
| 0.661 | 0.006 | 0.661 | Histamine release inhibitor | 0.526 0.021 DBMET02972 0.502 0.028 DBMET02973 0.407 0.072 DBMET02974 | ||
| 0.62 | 0.004 | 0.62 | Anesthetic local | 0.308 0.012 DBMET02972 0.338 0.01 DBMET02973 0.144 0.052 DBMET02974 | ||
| 0.601 | 0.004 | 0.601 | Cyclic AMP phosphodiesterase inhibitor | 0.378 0.02 DBMET02972 0.355 0.024 DBMET02973 0.299 0.042 DBMET02974 | ||
| 0.593 | 0.007 | 0.626 | Anticonvulsant | 0.626 0.006 DBMET02972 0.274 0.048 DBMET02973 | DBMET02972 | |
| 0.573 | 0.009 | 0.582 | Cardiotonic | 0.582 0.009 DBMET02972 0.258 0.077 DBMET02973 0.248 0.084 DBMET02974 | DBMET02972 | |
| 0.497 | 0.003 | 0.497 | Nav1.6 sodium channel blocker | 0.277 0.007 DBMET02972 0.276 0.007 DBMET02973 0.139 0.068 DBMET02974 | ||
| 0.493 | 0.004 | 0.493 | Nav1.3 sodium channel blocker | 0.24 0.015 DBMET02972 0.284 0.01 DBMET02973 | ||
| 0.532 | 0.049 | 0.688 | Caspase 9 stimulant | 0.281 0.216 DBMET02972 0.688 0.025 DBMET02973 | DBMET02973 | |
| 0.448 | 0.006 | 0.448 | 5 Hydroxytryptamine 2B antagonist | 0.191 0.028 DBMET02972 0.377 0.01 DBMET02973 | ||
| 0.419 | 0.005 | 0.419 | Alpha 2b adrenoreceptor antagonist | 0.212 0.021 DBMET02972 0.235 0.017 DBMET02973 | ||
| 0.415 | 0.006 | 0.415 | Nav1.2 sodium channel blocker | 0.193 0.037 DBMET02972 0.228 0.026 DBMET02973 | ||
| 0.41 | 0.032 | 0.41 | Vasodilator, coronary | 0.281 0.104 DBMET02972 0.381 0.042 DBMET02973 0.301 0.087 DBMET02974 | ||
| 0.358 | 0.007 | 0.358 | 5 Hydroxytryptamine 2C antagonist | 0.134 0.031 DBMET02972 0.326 0.008 DBMET02973 | ||
| 0.37 | 0.028 | 0.399 | Psychostimulant | 0.367 0.028 DBMET02972 0.399 0.023 DBMET02973 | DBMET02973 | |
| 0.358 | 0.02 | 0.377 | P-glycoprotein inhibitor | 0.377 0.019 DBMET02972 | DBMET02972 | |
| 0.36 | 0.051 | 0.36 | Nootropic | 0.215 0.139 DBMET02972 | ||
| 0.32 | 0.015 | 0.32 | 5 Hydroxytryptamine 2 antagonist | 0.12 0.059 DBMET02972 0.3 0.016 DBMET02973 | ||
| 0.31 | 0.009 | 0.31 | Calcium channel blocker | 0.291 0.011 DBMET02972 0.212 0.026 DBMET02973 0.116 0.092 DBMET02974 | ||
| 0.295 | 0.007 | 0.378 | Histamine H1 receptor antagonist | 0.378 0.005 DBMET02972 0.117 0.033 DBMET02973 | DBMET02972 | |
| 0.3 | 0.014 | 0.3 | Acetylcholine M1 receptor antagonist | 0.197 0.043 DBMET02972 0.198 0.043 DBMET02973 0.119 0.109 DBMET02974 | ||
| 0.289 | 0.011 | 0.374 | Antihistaminic | 0.374 0.007 DBMET02972 0.126 0.04 DBMET02973 0.104 0.052 DBMET02974 | DBMET02972 | |
| 0.273 | 0.008 | 0.273 | Alpha 2c adrenoreceptor antagonist | 0.129 0.043 DBMET02972 0.147 0.034 DBMET02973 | ||
| 0.273 | 0.009 | 0.276 | 5 Hydroxytryptamine 3E antagonist | 0.254 0.014 DBMET02972 0.276 0.008 DBMET02973 | DBMET02973 | |
| 0.275 | 0.012 | 0.275 | Butyrylcholinesterase inhibitor | 0.143 0.037 DBMET02973 | ||
| 0.274 | 0.013 | 0.274 | 5 Hydroxytryptamine 2A antagonist | 0.093 0.051 DBMET02972 0.223 0.017 DBMET02973 | ||
| 0.271 | 0.018 | 0.271 | Cholinergic antagonist | 0.168 0.043 DBMET02972 0.179 0.038 DBMET02973 0.251 0.021 DBMET02974 | ||
| 0.263 | 0.012 | 0.314 | Histamine antagonist | 0.314 0.009 DBMET02972 0.111 0.042 DBMET02973 0.085 0.058 DBMET02974 | DBMET02972 | |
| 0.256 | 0.014 | 0.256 | Acetylcholine muscarinic antagonist | 0.179 0.03 DBMET02972 0.134 0.055 DBMET02973 | ||
| 0.29 | 0.05 | 0.29 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.099 DBMET02972 0.288 0.052 DBMET02973 | ||
| 0.302 | 0.069 | 0.557 | 5 Hydroxytryptamine release stimulant | 0.332 0.061 DBMET02972 0.557 0.019 DBMET02973 | DBMET02973 | |
| 0.25 | 0.02 | 0.25 | Acetylcholine antagonist | 0.156 0.047 DBMET02972 0.164 0.043 DBMET02973 0.239 0.022 DBMET02974 | ||
| 0.249 | 0.025 | 0.249 | 5 Hydroxytryptamine antagonist | 0.094 0.085 DBMET02972 0.222 0.029 DBMET02973 | ||
| 0.271 | 0.053 | 0.271 | 5 Hydroxytryptamine 1E antagonist | 0.178 0.157 DBMET02972 0.266 0.058 DBMET02973 | ||
| 0.228 | 0.011 | 0.228 | Alpha 2a adrenoreceptor antagonist | 0.082 0.047 DBMET02972 0.109 0.033 DBMET02973 | ||
| 0.264 | 0.05 | 0.275 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.275 0.04 DBMET02973 | DBMET02973 | |
| 0.222 | 0.011 | 0.222 | Falcipain inhibitor | 0.107 0.051 DBMET02972 | ||
| 0.239 | 0.028 | 0.331 | Antipruritic | 0.331 0.01 DBMET02972 0.205 0.046 DBMET02973 | DBMET02972 | |
| 0.22 | 0.01 | 0.22 | Falcipain 2 inhibitor | 0.105 0.049 DBMET02972 | ||
| 0.211 | 0.005 | 0.211 | Acetylcholine M4 receptor antagonist | 0.121 0.017 DBMET02972 0.091 0.036 DBMET02973 | ||
| 0.21 | 0.005 | 0.21 | Calcium channel L-type blocker | 0.149 0.01 DBMET02972 0.115 0.018 DBMET02973 0.078 0.041 DBMET02974 | ||
| 0.211 | 0.008 | 0.211 | Sphingomyelinase inhibitor | 0.113 0.047 DBMET02972 0.204 0.009 DBMET02973 | ||
| 0.214 | 0.014 | 0.214 | Calcium channel (voltage-sensitive) blocker | 0.17 0.025 DBMET02972 0.145 0.036 DBMET02973 | ||
| 0.199 | 0.005 | 0.199 | Histamine H2 receptor antagonist | 0.127 0.017 DBMET02972 0.135 0.014 DBMET02973 | ||
| 0.209 | 0.016 | 0.209 | Alpha 2 adrenoreceptor antagonist | 0.078 0.069 DBMET02972 0.099 0.049 DBMET02973 | ||
| 0.275 | 0.084 | 0.275 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.255 0.102 DBMET02973 | ||
| 0.199 | 0.013 | 0.199 | Acetylcholine nicotinic antagonist | 0.089 0.047 DBMET02972 0.127 0.028 DBMET02973 | ||
| 0.191 | 0.006 | 0.191 | Histamine N-methyltransferase inhibitor | 0.116 0.032 DBMET02972 0.176 0.008 DBMET02973 | ||
| 0.332 | 0.149 | 0.332 | MAP kinase 1 inhibitor | |||
| 0.263 | 0.085 | 0.282 | Insulysin inhibitor | 0.194 0.167 DBMET02972 0.282 0.071 DBMET02973 | DBMET02973 | |
| 0.188 | 0.016 | 0.188 | Photosensitizer | 0.111 0.069 DBMET02972 0.151 0.03 DBMET02973 | ||
| 0.205 | 0.033 | 0.205 | NADPH oxidase inhibitor | 0.149 0.055 DBMET02973 | ||
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.148 0.047 DBMET02972 0.166 0.017 DBMET02973 0.131 0.115 DBMET02974 | ||
| 0.188 | 0.021 | 0.219 | Nav1.1 sodium channel blocker | 0.219 0.016 DBMET02973 | DBMET02973 | |
| 0.178 | 0.012 | 0.178 | 5 Hydroxytryptamine 1F antagonist | 0.169 0.014 DBMET02973 | ||
| 0.183 | 0.024 | 0.191 | Adenylate cyclase stimulant | 0.144 0.074 DBMET02972 0.191 0.018 DBMET02973 | DBMET02973 | |
| 0.253 | 0.098 | 0.253 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.168 | 0.013 | 0.168 | Dopamine D1 antagonist | 0.06 0.05 DBMET02972 0.065 0.044 DBMET02973 0.063 0.046 DBMET02974 | ||
| 0.234 | 0.085 | 0.24 | Tyrosine 3 hydroxylase inhibitor | 0.216 0.11 DBMET02972 0.24 0.079 DBMET02973 0.194 0.147 DBMET02974 | DBMET02973 | |
| 0.162 | 0.022 | 0.162 | DNA repair enzyme inhibitor | 0.155 0.027 DBMET02973 | ||
| 0.323 | 0.183 | 0.382 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.268 0.259 DBMET02972 0.382 0.117 DBMET02973 | DBMET02973 | |
| 0.166 | 0.029 | 0.166 | Calcium channel N-type blocker | 0.157 0.034 DBMET02972 0.161 0.031 DBMET02973 | ||
| 0.235 | 0.098 | 0.235 | Transcription factor STAT inhibitor | 0.218 0.114 DBMET02973 | ||
| 0.168 | 0.037 | 0.171 | MAP3K9 inhibitor | 0.131 0.093 DBMET02972 0.171 0.034 DBMET02973 | DBMET02973 | |
| 0.146 | 0.015 | 0.146 | Alpha 1d adrenoreceptor antagonist | 0.052 0.047 DBMET02973 | ||
| 0.153 | 0.021 | 0.153 | Alpha 1b adrenoreceptor antagonist | 0.061 0.059 DBMET02973 | ||
| 0.222 | 0.092 | 0.222 | Calpain inhibitor | 0.22 0.095 DBMET02973 | ||
| 0.137 | 0.009 | 0.137 | Acetylcholine M5 receptor antagonist | 0.069 0.032 DBMET02972 0.057 0.047 DBMET02973 | ||
| 0.135 | 0.008 | 0.135 | 5 Hydroxytryptamine 6 antagonist | 0.09 0.018 DBMET02972 0.067 0.031 DBMET02973 | ||
| 0.267 | 0.14 | 0.277 | GABA C receptor rho-3 antagonist | 0.204 0.203 DBMET02972 0.277 0.132 DBMET02973 | DBMET02973 | |
| 0.214 | 0.092 | 0.214 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.164 0.126 DBMET02973 | ||
| 0.249 | 0.128 | 0.267 | Vasodilator, peripheral | 0.267 0.115 DBMET02972 0.243 0.132 DBMET02973 0.205 0.17 DBMET02974 | DBMET02972 | |
| 0.155 | 0.035 | 0.155 | Heat shock protein 70 antagonist | 0.149 0.047 DBMET02973 | ||
| 0.132 | 0.012 | 0.132 | Adrenaline uptake inhibitor | 0.073 0.032 DBMET02972 0.098 0.019 DBMET02973 | ||
| 0.147 | 0.027 | 0.147 | Protein kinase C mu inhibitor | 0.146 0.028 DBMET02973 | ||
| 0.147 | 0.033 | 0.147 | Protein kinase C gamma inhibitor | 0.106 0.067 DBMET02972 0.11 0.062 DBMET02973 | ||
| 0.275 | 0.162 | 0.275 | Analgesic | |||
| 0.131 | 0.02 | 0.131 | Opioid kappa receptor antagonist | 0.092 0.043 DBMET02972 0.105 0.031 DBMET02973 0.086 0.049 DBMET02974 | ||
| 0.137 | 0.027 | 0.137 | Calcium antagonist | 0.097 0.05 DBMET02973 | ||
| 0.133 | 0.027 | 0.133 | 5 Hydroxytryptamine 1 antagonist | 0.126 0.028 DBMET02973 | ||
| 0.253 | 0.147 | 0.28 | Calpain 2 inhibitor | 0.28 0.127 DBMET02973 | DBMET02973 | |
| 0.143 | 0.038 | 0.143 | Chelator | 0.102 0.075 DBMET02974 | ||
| 0.135 | 0.03 | 0.135 | Opioid antagonist | 0.103 0.046 DBMET02972 0.089 0.058 DBMET02973 0.092 0.054 DBMET02974 | ||
| 0.127 | 0.024 | 0.127 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.032 DBMET02973 | ||
| 0.129 | 0.026 | 0.3 | 5 Hydroxytryptamine agonist | 0.058 0.057 DBMET02972 0.3 0.008 DBMET02973 | DBMET02973 | |
| 0.115 | 0.013 | 0.115 | Protein kinase C eta inhibitor | 0.075 0.026 DBMET02972 0.066 0.03 DBMET02973 | ||
| 0.129 | 0.027 | 0.129 | Protein kinase C zeta inhibitor | 0.093 0.06 DBMET02972 0.091 0.063 DBMET02973 | ||
| 0.106 | 0.012 | 0.136 | Phospholipase D inhibitor | 0.076 0.04 DBMET02972 0.136 0.004 DBMET02973 | DBMET02973 | |
| 0.118 | 0.024 | 0.118 | Glutamate release inhibitor | 0.115 0.025 DBMET02973 | ||
| 0.111 | 0.018 | 0.111 | Acetylcholine M2 receptor antagonist | 0.075 0.033 DBMET02972 | ||
| 0.133 | 0.041 | 0.133 | Antiadrenergic | |||
| 0.159 | 0.069 | 0.159 | Cytidine deaminase inhibitor | 0.136 0.086 DBMET02973 | ||
| 0.116 | 0.027 | 0.116 | 5 Hydroxytryptamine 1A antagonist | 0.074 0.043 DBMET02973 | ||
| 0.132 | 0.043 | 0.132 | Alpha adrenoreceptor antagonist | |||
| 0.14 | 0.052 | 0.14 | Adenylate cyclase inhibitor | 0.14 0.052 DBMET02973 | ||
| 0.194 | 0.109 | 0.559 | Vasodilator | 0.219 0.09 DBMET02973 0.559 0.008 DBMET02974 | DBMET02974 | |
| 0.129 | 0.045 | 0.13 | Transcription factor STAT6 inhibitor | 0.13 0.044 DBMET02973 | DBMET02973 | |
| 0.212 | 0.13 | 0.237 | Gastrin inhibitor | 0.18 0.178 DBMET02972 0.237 0.095 DBMET02973 | DBMET02973 | |
| 0.124 | 0.042 | 0.124 | Adrenaline antagonist | |||
| 0.092 | 0.011 | 0.155 | 5 Hydroxytryptamine 2 agonist | 0.062 0.024 DBMET02972 0.155 0.005 DBMET02973 | DBMET02973 | |
| 0.093 | 0.017 | 0.093 | Protein kinase C beta inhibitor | 0.063 0.062 DBMET02972 0.073 0.042 DBMET02973 | ||
| 0.094 | 0.018 | 0.094 | 5 Hydroxytryptamine 3 agonist | 0.058 0.052 DBMET02973 | ||
| 0.104 | 0.029 | 0.104 | Analgesic, opioid | 0.078 0.05 DBMET02972 0.071 0.061 DBMET02974 | ||
| 0.123 | 0.051 | 0.123 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.075 DBMET02973 | ||
| 0.093 | 0.023 | 0.096 | Vanilloid 4 agonist | 0.075 0.052 DBMET02972 0.096 0.02 DBMET02973 | DBMET02973 | |
| 0.157 | 0.09 | 0.159 | ATPase inhibitor | 0.159 0.088 DBMET02973 | DBMET02973 | |
| 0.231 | 0.165 | 0.231 | Immunosuppressant | |||
| 0.12 | 0.054 | 0.12 | Falcipain 3 inhibitor | |||
| 0.093 | 0.029 | 0.093 | 5 Hydroxytryptamine uptake inhibitor | 0.062 0.044 DBMET02973 | ||
| 0.065 | 0.005 | 0.065 | ATM kinase inhibitor | 0.06 0.005 DBMET02973 | ||
| 0.116 | 0.06 | 0.176 | DNA intercalator | 0.176 0.033 DBMET02973 | DBMET02973 | |
| 0.066 | 0.009 | 0.072 | Benzodiazepine antagonist | 0.072 0.007 DBMET02972 0.055 0.019 DBMET02973 | DBMET02972 | |
| 0.071 | 0.017 | 0.071 | 5 Hydroxytryptamine 4 antagonist | 0.052 0.035 DBMET02972 0.053 0.032 DBMET02973 | ||
| 0.085 | 0.03 | 0.085 | Dopamine D3 antagonist | |||
| 0.075 | 0.022 | 0.075 | Sigma receptor antagonist | 0.044 0.038 DBMET02972 | ||
| 0.076 | 0.027 | 0.076 | Dopamine uptake inhibitor | 0.066 0.033 DBMET02973 | ||
| 0.123 | 0.075 | 0.131 | Alpha-N-acetylglucosaminidase inhibitor | 0.131 0.068 DBMET02973 | DBMET02973 | |
| 0.075 | 0.028 | 0.075 | Acetylcholine M3 receptor antagonist | |||
| 0.18 | 0.133 | 0.18 | Immunostimulant | |||
| 0.093 | 0.046 | 0.093 | Alpha 1 adrenoreceptor antagonist | |||
| 0.099 | 0.058 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.091 0.071 DBMET02973 | ||
| 0.065 | 0.024 | 0.065 | Myc inhibitor | 0.065 0.024 DBMET02973 | ||
| 0.056 | 0.02 | 0.056 | Adenylate cyclase 1 inhibitor | 0.051 0.025 DBMET02973 | ||
| 0.082 | 0.046 | 0.082 | Dopamine antagonist | 0.071 0.053 DBMET02972 | ||
| 0.094 | 0.059 | 0.094 | Alcohol dehydrogenase inhibitor | 0.084 0.074 DBMET02973 | ||
| 0.09 | 0.055 | 0.09 | Acetylcholine agonist | |||
| 0.076 | 0.041 | 0.076 | Dopamine D2 antagonist | 0.075 0.041 DBMET02972 | ||
| 0.095 | 0.061 | 0.095 | Prolactin inhibitor | |||
| 0.084 | 0.052 | 0.084 | Caspase 7 inhibitor | |||
| 0.128 | 0.098 | 0.128 | Cholinergic | |||
| 0.2 | 0.169 | 0.417 | Caspase 3 stimulant | 0.417 0.039 DBMET02973 | DBMET02973 | |
| 0.042 | 0.012 | 0.074 | Benzodiazepine receptor peripheral-type antagonist | 0.074 0.004 DBMET02972 0.034 0.023 DBMET02973 | DBMET02972 | |
| 0.054 | 0.025 | 0.054 | 5 Hydroxytryptamine 2C agonist | 0.039 0.037 DBMET02972 0.041 0.036 DBMET02973 | ||
| 0.143 | 0.114 | 0.156 | 3C-like protease (Human coronavirus) inhibitor | 0.156 0.092 DBMET02973 | DBMET02973 | |
| 0.172 | 0.144 | 0.172 | MAP-kinase-activated kinase 5 inhibitor | 0.17 0.148 DBMET02973 | ||
| 0.095 | 0.069 | 0.149 | Nitric-oxide synthase inhibitor | 0.149 0.023 DBMET02973 | DBMET02973 | |
| 0.043 | 0.019 | 0.043 | Gonadotropin-releasing hormone receptor antagonist | 0.039 0.021 DBMET02972 | ||
| 0.066 | 0.042 | 0.07 | Beta 3 adrenoreceptor antagonist | 0.07 0.035 DBMET02973 | DBMET02973 | |
| 0.103 | 0.08 | 0.103 | Acetylcholine release stimulant | |||
| 0.072 | 0.049 | 0.072 | Alpha 1a adrenoreceptor antagonist | |||
| 0.096 | 0.075 | 0.096 | Adenylate kinase inhibitor | |||
| 0.152 | 0.131 | 0.152 | Insulin sensitizer | |||
| 0.066 | 0.045 | 0.092 | 5 Hydroxytryptamine 1B antagonist | 0.092 0.027 DBMET02973 | DBMET02973 | |
| 0.035 | 0.017 | 0.035 | Peptide deformylase inhibitor | 0.03 0.021 DBMET02973 | ||
| 0.121 | 0.103 | 0.121 | Diuretic | |||
| 0.089 | 0.072 | 0.126 | MAO A inhibitor | 0.083 0.077 DBMET02972 0.126 0.049 DBMET02973 | DBMET02973 | |
| 0.061 | 0.045 | 0.067 | Histone deacetylase SIRT3 inhibitor | 0.067 0.033 DBMET02973 | DBMET02973 | |
| 0.17 | 0.154 | 0.182 | Nitric-oxide synthase stimulant | 0.182 0.123 DBMET02973 | DBMET02973 | |
| 0.026 | 0.01 | 0.026 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 DBMET02973 | ||
| 0.179 | 0.165 | 0.179 | Transcription factor STAT3 inhibitor | |||
| 0.059 | 0.046 | 0.059 | 5 Hydroxytryptamine 5A antagonist | 0.057 0.051 DBMET02973 | ||
| 0.048 | 0.035 | 0.048 | Cytokine production stimulant | |||
| 0.058 | 0.045 | 0.058 | CDK2/cyclin E inhibitor | |||
| 0.108 | 0.095 | 0.125 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.125 0.08 DBMET02973 | DBMET02973 | |
| 0.055 | 0.043 | 0.055 | Glutamate (mGluR1) antagonist | |||
| 0.026 | 0.015 | 0.031 | Glutamate (mGluR1) agonist | 0.031 0.009 DBMET02973 | DBMET02973 | |
| 0.102 | 0.092 | 0.104 | Interleukin 8 antagonist | 0.104 0.088 DBMET02973 | DBMET02973 | |
| 0.029 | 0.019 | 0.029 | 5 Hydroxytryptamine 6 agonist | |||
| 0.091 | 0.081 | 0.146 | Mediator release inhibitor | 0.146 0.03 DBMET02972 | DBMET02972 | |
| 0.027 | 0.018 | 0.027 | Myristoyl transferase inhibitor | 0.026 0.022 DBMET02973 | ||
| 0.045 | 0.037 | 0.048 | Dopamine transporter inhibitor | 0.048 0.034 DBMET02973 | DBMET02973 | |
| 0.116 | 0.108 | 0.116 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.045 | 0.037 | 0.13 | Baculoviral IAP repeat-containing protein inhibitor | 0.13 0.003 DBMET02973 | DBMET02973 | |
| 0.034 | 0.027 | 0.034 | AMPA receptor agonist | |||
| 0.07 | 0.065 | 0.07 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 DBMET02973 | ||
| 0.08 | 0.075 | 0.08 | NADH dehydrogenase inhibitor | |||
| 0.028 | 0.024 | 0.028 | Acetylcholine M4 receptor agonist | |||
| 0.128 | 0.124 | 0.128 | LIM domain kinase 1 inhibitor | 0.127 0.125 DBMET02973 | ||
| 0.015 | 0.011 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.012 DBMET02974 | ||
| 0.049 | 0.046 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.053 | 0.05 | 0.053 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.046 | 0.044 | 0.046 | Squalene epoxidase inhibitor | |||
| 0.051 | 0.052 | 0.059 | Protein kinase C iota inhibitor | 0.059 0.042 DBMET02973 | DBMET02973 | |
| 0.04 | 0.041 | 0.045 | Histamine H1 receptor agonist | 0.045 0.027 DBMET02973 | DBMET02973 | |
| 0.026 | 0.028 | 0.049 | Endothelial nitric-oxide synthase inhibitor | 0.049 0.01 DBMET02973 | DBMET02973 | |
| 0.12 | 0.123 | 0.125 | Neuropeptide Y1 antagonist | 0.125 0.111 DBMET02973 | DBMET02973 | |
| 0.056 | 0.061 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | 0.06 0.052 DBMET02973 | DBMET02973 | |
| 0.05 | 0.061 | 0.059 | Immunoglobulin Fc receptor antagonist | 0.059 0.026 DBMET02973 | DBMET02973 | |
| 0.113 | 0.126 | 0.121 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.121 0.116 DBMET02973 | DBMET02973 | |
| 0.066 | 0.081 | 0.121 | Ca(v)2.2 blocker | 0.121 0.038 DBMET02973 | DBMET02973 | |
| 0.134 | 0.151 | 0.148 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.148 0.13 DBMET02973 | DBMET02973 | |
| 0.117 | 0.134 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.06 DBMET02972 | DBMET02972 | |
| 0.053 | 0.079 | 0.063 | Potassium channel (ATP-sensitive) blocker | 0.063 0.055 DBMET02973 | DBMET02973 | |
| 0.048 | 0.077 | 0.061 | Alpha adrenoreceptor agonist | 0.061 0.054 DBMET02973 | DBMET02973 | |
| 0.113 | 0.143 | 0.145 | GABA C receptor rho-2 antagonist | 0.145 0.081 DBMET02973 | DBMET02973 | |
| 0.063 | 0.094 | 0.117 | NMDA receptor antagonist | 0.117 0.037 DBMET02972 | DBMET02972 | |
| 0.017 | 0.049 | 0.04 | Histone deacetylase 4 inhibitor | 0.04 0.018 DBMET02973 | DBMET02973 | |
| 0.015 | 0.054 | 0.047 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.047 0.003 DBMET02973 | DBMET02973 | |
| 0.022 | 0.064 | 0.095 | Purinergic P2X3 antagonist | 0.095 0.005 DBMET02973 | DBMET02973 | |
| 0.006 | 0.049 | 0.028 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.028 0.002 DBMET02973 | DBMET02973 | |
| 0.052 | 0.096 | 0.071 | Glutamate dehydrogenase inhibitor | 0.071 0.055 DBMET02973 | DBMET02973 | |
| 0.035 | 0.08 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.033 DBMET02972 | DBMET02972 | |
| 0.036 | 0.083 | 0.051 | Potassium channel (Inward rectifier) activator | 0.051 0.034 DBMET02972 | DBMET02972 | |
| 0.033 | 0.081 | 0.063 | Cannabinoid CB1 receptor agonist | 0.063 0.04 DBMET02972 | DBMET02972 | |
| 0.038 | 0.089 | 0.052 | Carbonic anhydrase stimulant | 0.052 0.051 DBMET02973 | DBMET02973 | |
| 0.025 | 0.082 | 0.04 | Histamine H2 receptor agonist | 0.04 0.035 DBMET02973 | DBMET02973 | |
| 0.069 | 0.128 | 0.09 | GABA C receptor rho-1 antagonist | 0.09 0.078 DBMET02973 | DBMET02973 | |
| 0.042 | 0.101 | 0.059 | Histone deacetylase inhibitor | 0.059 0.055 DBMET02973 | DBMET02973 | |
| 0.04 | 0.106 | 0.056 | NMDA receptor agonist | 0.056 0.054 DBMET02973 | DBMET02973 | |
| 0.179 | 0.248 | 0.22 | Calcium channel activator | 0.22 0.185 DBMET02973 | DBMET02973 | |
| 0.02 | 0.091 | 0.046 | NMDA 2A receptor antagonist | 0.046 0.042 DBMET02973 | DBMET02973 | |
| 0.09 | 0.163 | 0.131 | Cell wall synthesis inhibitor | 0.131 0.085 DBMET02973 | DBMET02973 | |
| 0.033 | 0.107 | 0.051 | Phosphodiesterase 7A inhibitor | 0.051 0.038 DBMET02973 | DBMET02973 | |
| 0.044 | 0.119 | 0.079 | Telomerase inhibitor | 0.079 0.045 DBMET02972 | DBMET02972 | |
| 0.12 | 0.195 | 0.16 | Neurotensin receptor agonist | 0.16 0.08 DBMET02973 | DBMET02973 | |
| 0.043 | 0.12 | 0.061 | Caspase 9 inhibitor | 0.061 0.045 DBMET02973 | DBMET02973 | |
| 0.019 | 0.109 | 0.155 | Beta tubulin antagonist | 0.155 0.011 DBMET02972 0.077 0.031 DBMET02973 | DBMET02972 | |
| 0.148 | 0.254 | 0.197 | Antithrombotic | 0.197 0.181 DBMET02973 | DBMET02973 | |
| 0.005 | 0.146 | 0.018 | Cathepsin S inhibitor | 0.018 0.014 DBMET02973 | DBMET02973 | |
| 0.026 | 0.173 | 0.136 | Leukotriene synthesis inhibitor | 0.136 0.012 DBMET02972 | DBMET02972 | |
| 0.047 | 0.21 | 0.382 | Tubulin antagonist | 0.119 0.081 DBMET02972 0.382 0.013 DBMET02974 | DBMET02974 | |
| 0.124 | 0.289 | 0.167 | Peptidyltransferase inhibitor | 0.163 0.162 DBMET02972 0.167 0.154 DBMET02973 | DBMET02973 | |
| 0.004 | 0.195 | 0.07 | Estrogen receptor alpha agonist | 0.07 0.014 DBMET02974 | DBMET02974 | |
| 0.038 | 0.284 | 0.165 | Estrogen receptor beta antagonist | 0.165 0.013 DBMET02974 | DBMET02974 | |
| 0.047 | 0.307 | 0.157 | Estrogen antagonist | 0.157 0.021 DBMET02974 | DBMET02974 | |
| 0.067 | 0.35 | 0.24 | Antioxidant | 0.24 0.089 DBMET02974 | DBMET02974 | |
| 0.032 | 0.341 | 0.069 | MAP kinase kinase 8 inhibitor | 0.069 0.046 DBMET02973 | DBMET02973 | |
| 0.049 | 0.371 | 0.412 | Antimitotic | 0.412 0.021 DBMET02974 | DBMET02974 | |
| 0.11 | 0.446 | 0.545 | Apoptosis agonist | 0.545 0.062 DBMET02973 | DBMET02973 | |
| 0.003 | 0.344 | 0.037 | Estrogen receptor beta agonist | 0.037 0.022 DBMET02974 | DBMET02974 | |
| 0.039 | 0.482 | 0.205 | Tumour necrosis factor alpha release inhibitor | 0.205 0.105 DBMET02972 | DBMET02972 | |
| 0.031 | 0.496 | 0.234 | Interleukin 1 antagonist | 0.234 0.022 DBMET02972 | DBMET02972 | |
| 0.103 | 0.599 | 0.279 | Calcium channel L-type activator | 0.279 0.175 DBMET02973 | DBMET02973 | |
| 0.03 | 0.587 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.063 DBMET02973 | DBMET02973 | |
| 0.009 | 0.579 | 0.279 | Platelet activating factor antagonist | 0.279 0.013 DBMET02974 | DBMET02974 | |
| 0.023 | 0.624 | 0.237 | Interleukin 1b antagonist | 0.237 0.013 DBMET02972 | DBMET02972 | |
| 0.014 | 0.694 | 0.498 | Platelet aggregation inhibitor | 0.498 0.01 DBMET02974 | DBMET02974 | |
| 0.023 | 0.728 | 0.415 | Toll-Like receptor 7 agonist | 0.415 0.054 DBMET02974 | DBMET02974 | |
| 0.021 | 0.735 | 0.408 | Toll-Like receptor agonist | 0.408 0.057 DBMET02974 | DBMET02974 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |